Related Experiment Video

Updated: Jul 6, 2026

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
12:33

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

Published on: June 25, 2014

Loss of functional KATP channels in pancreatic beta-cells causes persistent hyperinsulinemic hypoglycemia of infancy

C Kane1, R M Shepherd, P E Squires

  • 1Department of Biomedical Science, University of Sheffield, UK.

Nature Medicine
|December 1, 1996
PubMed

Insights

Persistent hyperinsulinemic hypoglycemia of infancy (PHHI) is caused by pancreatic beta-cells lacking ATP-sensitive K+ channel activity. This leads to spontaneous electrical activity and excessive insulin secretion, defining a new K+ channel disorder.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Pediatric Medicine

Background:

  • Persistent hyperinsulinemic hypoglycemia of infancy (PHHI) is a critical pediatric condition characterized by excessive insulin secretion.
  • The underlying causes of PHHI have remained largely debated in scientific literature.

Purpose of the Study:

  • To investigate the molecular mechanisms and cellular basis of persistent hyperinsulinemic hypoglycemia of infancy (PHHI).
  • To elucidate the role of ion channels in the pathogenesis of PHHI.

Main Methods:

  • Electrophysiological analysis of pancreatic beta-cells from infants diagnosed with PHHI.
  • Measurement of cytosolic calcium concentrations in PHHI beta-cells.
  • Assessment of ATP-sensitive K+ channel (KATP) activity.

Main Results:

  • Insulin-secreting cells from PHHI infants demonstrated a complete absence of ATP-sensitive K+ channel (KATP) activity.
  • PHHI beta-cells exhibited spontaneous electrical activity.
  • Elevated basal cytosolic calcium concentrations were observed in PHHI beta-cells, resulting from continuous calcium influx.

Conclusions:

  • The pathogenesis of PHHI is identified as a novel potassium (K+) channel disorder.
  • Dysfunctional KATP channels in pancreatic beta-cells lead to uncontrolled insulin secretion in PHHI.
  • These findings provide a new molecular understanding of PHHI, paving the way for targeted therapies.

More Related Videos

Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors09:23

Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors

Published on: March 7, 2017

Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro09:33

Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro

Published on: June 2, 2018

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.